HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Susanna Amadio Selected Research

Histamine Agents

6/2022Repurposing Histaminergic Drugs in Multiple Sclerosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Susanna Amadio Research Topics

Disease

10Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
01/2022 - 10/2013
8Multiple Sclerosis
06/2022 - 06/2010
6Neuroinflammatory Diseases
01/2022 - 09/2014
5Disease Progression
01/2022 - 01/2016
4Demyelinating Diseases (Demyelinating Disease)
06/2022 - 06/2010
3Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
12/2021 - 01/2017
2Motor Neuron Disease (Primary Lateral Sclerosis)
01/2022 - 01/2017
2Gliosis
12/2021 - 10/2013
2Inflammation (Inflammations)
01/2017 - 01/2017
2Neurodegenerative Diseases (Neurodegenerative Disease)
01/2016 - 01/2009
2Brain Ischemia (Cerebral Ischemia)
09/2014 - 12/2003
2Hypoglycemia (Reactive Hypoglycemia)
10/2004 - 12/2003
1Coronary Artery Disease (Coronary Atherosclerosis)
01/2022
1Chromosome Aberrations (Chromosome Abnormalities)
01/2021
1Mason-Type Diabetes
01/2021
1Type 2 Maturity-Onset Diabetes of the Young
01/2021
1Hyperglycemia
01/2021
1Genomic Instability
01/2021
1Obesity
01/2021
1Neoplasms (Cancer)
01/2021
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2021
1Muscular Dystrophies (Muscular Dystrophy)
01/2021
1Relapsing-Remitting Multiple Sclerosis
01/2020
1Muscular Atrophy (Muscle Atrophy)
01/2019
1Brain Diseases (Brain Disorder)
01/2017
1Autoimmune Diseases of the Nervous System
09/2014
1Traumatic Brain Injuries (Traumatic Brain Injury)
09/2014
1Neuralgia (Stump Neuralgia)
09/2014
1Body Weight (Weight, Body)
10/2013
1Ischemia
10/2007
1Parkinson Disease (Parkinson's Disease)
09/2007
1Brain Infarction
07/2006
1Infarction (Infarctions)
07/2006
1Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
07/2006
1Neuroblastoma
02/2005
1Starvation
10/2004
1Chronic Disease (Chronic Diseases)
12/2003
1Hypoxia (Hypoxemia)
12/2003
1Wounds and Injuries (Trauma)
12/2003

Drug/Important Bio-Agent (IBA)

8Pharmaceutical PreparationsIBA
06/2022 - 09/2014
6Histamine (Histamine Dihydrochloride)FDA Link
06/2022 - 01/2016
5Purinergic P2X7 ReceptorsIBA
09/2021 - 07/2006
4Proteins (Proteins, Gene)FDA Link
12/2021 - 10/2004
2CytokinesIBA
12/2021 - 01/2017
2Pentamidine (NebuPent)FDA LinkGeneric
12/2021 - 01/2020
2coomassie Brilliant BlueIBA
09/2021 - 09/2014
2EnzymesIBA
01/2021 - 01/2017
2Glucose (Dextrose)FDA LinkGeneric
01/2021 - 10/2004
2Clemastine (Clemastine Fumarate)FDA LinkGeneric
01/2016 - 01/2016
2Adenosine Triphosphate (ATP)IBA
01/2009 - 12/2003
1rupatadineIBA
06/2022
1Amodiaquine (Camoquin)FDA Link
06/2022
1Diphenhydramine (Benadryl)FDA LinkGeneric
06/2022
1Histamine AgentsIBA
06/2022
1Trimetazidine (Vastarel)IBA
01/2022
1ONO2506IBA
12/2021
1AntioxidantsIBA
01/2021
1GlucokinaseIBA
01/2021
1Advanced Glycation End ProductsIBA
01/2021
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2021
1Vitamin B 6IBA
01/2021
1Hexosaminidase A (Hex A)IBA
01/2021
1Nerve Growth Factors (Neurotrophins)IBA
01/2021
1Nerve Growth Factor (NGF)IBA
01/2021
1Retinaldehyde (Retinal)IBA
01/2021
1Neurotransmitter Agents (Neurotransmitter)IBA
10/2019
1Histidine (L-Histidine)FDA Link
01/2019
1Histamine N-MethyltransferaseIBA
01/2017
1Histidine DecarboxylaseIBA
01/2017
1Histamine H4 ReceptorsIBA
01/2017
1Amine Oxidase (Copper-Containing)IBA
01/2017
1Histamine H1 Receptors (Histamine H1 Receptor)IBA
01/2016
1Superoxide Dismutase-1IBA
01/2016
1Purinergic P2X1 ReceptorsIBA
10/2007
1Oxidopamine (6 Hydroxydopamine)IBA
09/2007
1Dopamine (Intropin)FDA LinkGeneric
09/2007
1Cibacron Blue F 3GAIBA
07/2006
1purinoceptor P2Y4IBA
02/2005
1N-Methylaspartate (NMDA)IBA
10/2004
1NMDA receptor A1IBA
10/2004
1PotassiumIBA
12/2003
1Glutamic Acid (Glutamate)FDA Link
12/2003

Therapy/Procedure

1Denervation
09/2007